Immunohistochemical staining of clinical cancer tissues further confirmed higher CD133 expression in liver, lung, colorectal, and gastric cancers, contrasted with adjacent tissues (Figs. 1F and EV1A). The gene discussed is PROM1; the disease is gastric cancer.